Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 100

    1.

    Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus.

    Pettitt DJ, Ospina P, Kolaczynski JW, Jovanovic L.

    Diabetes Care. 2003 Jan;26(1):183-6.PMID: 12502678 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.

    Jovanovic L, Giammattei J, Acquistapace M, Bornstein K, Sommermann E, Pettitt DJ.

    Clin Ther. 2004 Sep;26(9):1492-7.PMID: 15531011 [PubMed - indexed for MEDLINE]Related articles

    3.

    Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus.

    Pettitt DJ, Ospina P, Howard C, Zisser H, Jovanovic L.

    Diabet Med. 2007 Oct;24(10):1129-35.PMID: 17888133 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Optimal dose and timing of insulin Aspart to mimic first phase insulin response in patients with recently onset type 2 diabetes.

    Gredal C, Rosenfalck A, Dejgaard A, Hilsted J.

    Diabetes Res Clin Pract. 2008 May;80(2):293-8. Epub 2008 Mar 4.PMID: 18304675 [PubMed - indexed for MEDLINE]Related articles

    5.

    Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin.

    Rosenfalck AM, Thorsby P, Kjems L, Birkeland K, Dejgaard A, Hanssen KF, Madsbad S.

    Acta Diabetol. 2000 Mar;37(1):41-6.PMID: 10928235 [PubMed - indexed for MEDLINE]Related articles

    6.

    Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes.

    Lindholm A, McEwen J, Riis AP.

    Diabetes Care. 1999 May;22(5):801-5.PMID: 10332685 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Metabolic and immunologic effects of insulin lispro in gestational diabetes.

    Jovanovic L, Ilic S, Pettitt DJ, Hugo K, Gutierrez M, Bowsher RR, Bastyr EJ 3rd.

    Diabetes Care. 1999 Sep;22(9):1422-7.PMID: 10480503 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.

    Weyer C, Gottlieb A, Kim DD, Lutz K, Schwartz S, Gutierrez M, Wang Y, Ruggles JA, Kolterman OG, Maggs DG.

    Diabetes Care. 2003 Nov;26(11):3074-9.PMID: 14578242 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control.

    Chisalita SI, Lindström T, Eson Jennersjö P, Paulsson JF, Westermark GT, Olsson AG, Arnqvist HJ.

    Acta Diabetol. 2009 Mar;46(1):35-42. Epub 2008 Sep 6.PMID: 18777156 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.

    Burge MR, Waters DL, Holcombe JH, Schade DS.

    J Clin Endocrinol Metab. 1997 Mar;82(3):920-4.PMID: 9062507 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women.

    Mecacci F, Carignani L, Cioni R, Bartoli E, Parretti E, La Torre P, Scarselli G, Mello G.

    Eur J Obstet Gynecol Reprod Biol. 2003 Nov 10;111(1):19-24.PMID: 14557006 [PubMed - indexed for MEDLINE]Related articles

    13.

    Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.

    Malone JK, Woodworth JR, Arora V, Yang H, Campaigne BN, Hallé JP, Yale JF, Grossman LD.

    Clin Ther. 2000 Feb;22(2):222-30.PMID: 10743981 [PubMed - indexed for MEDLINE]Related articles

    14.

    Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes.

    Hermansen K, Colombo M, Storgaard H, ØStergaard A, Kølendorf K, Madsbad S.

    Diabetes Care. 2002 May;25(5):883-8.PMID: 11978685 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    [Intensified insulin therapy of type 2 diabetes mellitus: pre- or postprandial injection of aspart insulin?]

    Jungmann E.

    Dtsch Med Wochenschr. 2005 May 20;130(20):1254-7. German. PMID: 15889321 [PubMed - indexed for MEDLINE]Related articles

    16.

    Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy.

    Kautzky-Willer A, Prager R, Waldhausl W, Pacini G, Thomaseth K, Wagner OF, Ulm M, Streli C, Ludvik B.

    Diabetes Care. 1997 Nov;20(11):1717-23.PMID: 9353615 [PubMed - indexed for MEDLINE]Related articles

    17.

    Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.

    Koivisto VA, Tuominen JA, Ebeling P.

    Diabetes Care. 1999 Mar;22(3):459-62.PMID: 10097929 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients.

    Pala L, Mannucci E, Dicembrini I, Rotella CM.

    Diabetes Res Clin Pract. 2007 Oct;78(1):132-5. Epub 2007 Apr 18.PMID: 17445933 [PubMed - indexed for MEDLINE]Related articles

    19.

    Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.

    Ashwell SG, Gebbie J, Home PD.

    Diabet Med. 2006 Aug;23(8):879-86.PMID: 16911626 [PubMed - indexed for MEDLINE]Related articles

    20.

    Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.

    Mudaliar SR, Lindberg FA, Joyce M, Beerdsen P, Strange P, Lin A, Henry RR.

    Diabetes Care. 1999 Sep;22(9):1501-6.PMID: 10480516 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data